Stock screener

CVS

Conviction 80HealthcareScan · Mon, Jul 20, 2026
Shooting star
CVS$107.59+0.11%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
2
4
2
Vol MA14 7.35M
Apr 20May 6May 26Jun 11Jul 1Jul 20
WSB mentions · 24h changelatest +0.00%· 1 mentions
Apr 20May 6May 26Jun 11Jul 1Jul 20
CVS HEALTH CorpRETAIL-DRUG STORES AND PROPRIETARY STORESwww.cvshealth.com
Price107.59
Change+0.11%
Gap-0.10%
Rel volume0.82×
Avg volume7.55M
Avg $ vol789.07M
SMA 20104.38
SMA 5098.73
SMA 20083.23
Price vs 50+8.97%
Price vs 200+29.27%
MA stackbullish
50/200 cross
Supertrendup · 100.37
RSI (14)68
MACD hist-0.07
MACD cross
Stoch %K / %D81 / 76
ADX (14)35
+DI / −DI21 / 13
RSI divergence
MACD divergence
ATR %+2.34%
ADR %2.36%
52w high107.59
52w low58.75
From 52w high+0.00%
Above 52w low+83.13%
New 52w highYes
SqueezeOff
Bollinger width6.94%
%B0.94
Donchian pos86.16%
Donchian high108.97
Donchian low99.00
AVWAP (52w high)107.77
vs AVWAP high-0.17%
AVWAP (52w low)80.50
vs AVWAP low+33.66%
OBV trendUp
Chaikin MF (20)0.05
Today vs 20d0.82×
Avg vol (14d)7.35M
Avg vol (20d)7.55M
Avg $ vol (20d)789.07M
Market cap137.28B
RS 3m (vs SPY)+34.02%
RS 6m (vs SPY)+27.81%
RS line new highYes
Trend template8/8
Technical rank90.1
1 week+1.60%
1 month+8.50%
3 months+39.18%
6 months+32.24%
1 year+69.97%
YTD+34.27%
P/E77.65
P/B1.77
P/S0.71
P/FCF17.58
EPS1.39
Div yield2.47%
ROE2.28%
ROA0.70%
Debt/Eq0.93
Current0.87
EV/EBITDA21.52
Gross margin14.72%
Net margin0.91%
Rev growth4.95%
EPS growth-61.68%
Price target110.13
Target upside2.36%
Analyst ratingBuy
Institutional98.28%
Ent. value199.41B
Revenue64.55B
Net income2.94B
Gross profit7.33B
Free cash flow7.81B
IndustryRETAIL-DRUG STORES AND PROPRIETARY STORES
ExchangeNYSE
Shares out1.28B
Employees300K
ListedWed, Oct 1, 1952
Free float1.26B
Float %99.3%
Short interest19.94M
Days to cover2.3d
Short volume58.8%
Squeeze score27 / 100
Next earningsWed, Aug 5, 2026 · pre-mkt (16d)
EPS forecast$1.87 · 8 est
Last EPS vs est$2.57 vs $2.21
Last surprise+16.3% beat
Setup gradeA
Conviction80 / 100
Pattern quality
Tech rank90.1 / 100
Group rank23 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmShooting star
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CVS · 10 recent

All disclosures →
MemberSideAmount
John Boozman
John Boozman
senate · R · AR · traded 2026-01-29
Buy$1K–$15K
Dwight Evans
Dwight Evans
house · PA · traded 2025-11-21
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-31
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Buy$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-09-23
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2024-10-29
Buy$1K–$15K
Adam Smith
Adam Smith
house · D · WA · traded 2025-08-08
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-05-12
Sell$15K–$50K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-04-01
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in CVS · 10 sells

InsiderSideShares
Clark James David
SVP, Cont & Chief Acct Officer · Common Stock (Restricted) · 2026-06-26
Tax454
Newman Brian
EVP, Chief Financial Officer · Common Stock · 2026-05-31
Tax2.48K
Compton-Phillips Amy
EVP, Chief Medical Officer · Common Stock · 2026-05-31
Tax7.62K
AGUIRRE FERNANDO
Director · Common Stock · 2026-05-21
Disposition1.56K
AGUIRRE FERNANDO
Director · Common Stock · 2026-05-20
Disposition30.44K
ROBBINS LARRY
Director · Cash-Settled Swaps · 2026-05-21
Sell378K
ROBBINS LARRY
Director · Common Stock · 2026-05-21
Sell370.46K
ROBBINS LARRY
Director · Common Stock · 2026-05-20
Sell797.63K
ROBBINS LARRY
Director · Common Stock · 2026-05-20
Sell800
ROBBINS LARRY
Director · Common Stock · 2026-05-20
Sell66.88K

SEC filings

EDGAR filings in CVS

EDGAR →

No recent SEC filings on file for CVS.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.